Beneficial effect of nitrates on myocardial glucose utilization in unstable angina pectoris
- PMID: 3500629
- DOI: 10.1016/0002-9149(87)90547-9
Beneficial effect of nitrates on myocardial glucose utilization in unstable angina pectoris
Abstract
Myocardial uptake of the glucose analog F-18-2-fluoro-2-deoxy-D-glucose (FDG) was assessed by positron emission tomography in 6 normal volunteers, 7 patients with chronic stable angina and 22 patients with unstable angina at rest in fasting conditions. Regional myocardial perfusion was assessed by rubidium-82. The study was repeated a few days later after intravenous infusion of isosorbide dinitrate. FDG uptake was similar in control subjects and patients with stable angina (0.023 +/- 0.032 vs 0.012 +/- 0.008 mol/ml/min, p less than 0.42) but was about 4-fold higher on the average in patients with unstable angina (0.084 +/- 0.047, p less than 0.01). The severity of coronary obstructions in stable and unstable angina patients was similar. The increased uptake involved the whole heart, including areas not distal to critically stenosed vessels; it was not associated with reduced myocardial perfusion and was not related to a recent episode of transient ischemia as assessed by symptoms and by Holter monitoring. After continuous infusion of nitrates, FDG uptake was consistently and significantly reduced toward normal levels both in areas perfused by critically stenosed coronary arteries and by noncritically stenosed vessels.
Similar articles
-
Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.Circulation. 1986 Jul;74(1):81-8. doi: 10.1161/01.cir.74.1.81. Circulation. 1986. PMID: 3486725
-
Myocardial glucose utilization in ischaemic heart disease: preliminary results with F18-fluorodeoxyglucose and positron emission tomography.Eur Heart J. 1986 Dec;7 Suppl C:19-23. doi: 10.1093/eurheartj/7.suppl_c.19. Eur Heart J. 1986. PMID: 3493137
-
Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography.Cardiovasc Drugs Ther. 1988 May;2(1):41-6. doi: 10.1007/BF00054251. Cardiovasc Drugs Ther. 1988. PMID: 3154693
-
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.Prog Cardiovasc Dis. 1989 Nov-Dec;32(3):217-38. doi: 10.1016/0033-0620(89)90027-3. Prog Cardiovasc Dis. 1989. PMID: 2682779 Review.
-
Regional myocardial glucose metabolism in angina pectoris obtained from positron emission tomography.J Thorac Imaging. 1988 Apr;3(2):56-63. doi: 10.1097/00005382-198804000-00007. J Thorac Imaging. 1988. PMID: 3283374 Review.
Cited by
-
Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease.J Nucl Cardiol. 1994 Mar-Apr;1(2 Pt 2):S34-9. doi: 10.1007/BF02940067. J Nucl Cardiol. 1994. PMID: 9420696 Review.
-
F-18 fluorodeoxyglucose imaging in myocardial ischemia: beyond myocardial viability.J Nucl Cardiol. 2001 May-Jun;8(3):417-20. doi: 10.1067/mnc.2001.115646. J Nucl Cardiol. 2001. PMID: 11391313 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical